Riskpilot← Back to searchSign inGet full accessDr. Wolff Sweden AB
ABActiveOrg 5592658065Jungmansgatan 12Activities of agents involved in the wholesale of other particular products · NACE 4618Est. 20201-4 employees
Revenue 2024
SEK 32,4M
+9% vs 2023
EBITDA margin
9.3%
+187% vs 2023
Equity ratio
32.3%
Financial strength
Net profit 2024
SEK 2,2M
+217% vs 2023
| Revenue | SEK 32,4M | +9% |
| EBITDA | SEK 3M | +187% |
| Net profit | SEK 2,2M | +217% |
| Total assets | SEK 13,1M | -7% |
| Equity | SEK 4,2M | +109% |
| Employees | — | — |
Legal name
Dr. Wolff Sweden AB
Org number
5592658065
Legal form
Aktiebolag
NACE code
4618 · Activities of agents involved in the wholesale of other particular products
Founded
4 augusti 2020
Share capital
SEK 100 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Aktiebolaget ska bedriva handel med kosmetika, medicintekniska produkter samt läkemedel och därmed förenlig verksamhet.
Address
Jungmansgatan 12
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 20 030 | 24 014 | 29 627 | 32 383 |
| Staff expenses | — | — | — | — |
| EBITDA | 931 | 623 | 1 052 | 3 019 |
| Depreciation & amort. | −0 | −0 | −0 | −0 |
| EBIT | 931 | 623 | 1 052 | 3 019 |
| Net financials | −4 | −2 | −169 | −235 |
| Profit before tax | 927 | 621 | 883 | 2 784 |
| Tax | −192 | −128 | −192 | −594 |
| Net profit | 735 | 493 | 691 | 2 190 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 11 029 | 12 470 | 14 070 | 13 050 |
| Equity | 835 | 1 328 | 2 019 | 4 210 |
| Long-term debt | 0 | 0 | 6 000 | 4 000 |
| Short-term debt | 10 194 | 11 142 | 6 051 | 4 840 |
| Total debt | 10 194 | 11 142 | 12 051 | 8 840 |
EBITDA margin
9.3%
This company
15.8%
Market median
-41% vs market
20212024
Equity ratio
32.3%
This company
38.2%
Market median
+15% vs market
20212024
Return on equity
52.0%
This company
18.4%
Market median
+183% vs market
20212024
Net profit margin
6.8%
This company
8.1%
Market median
-16% vs market
20212024
Asset turnover
2.48×
This company
1.12×
Market median
+121% vs market
20212024
Debt / equity
2.10×
This company
0.62×
Market median
-239% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-08-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
LM Chief Auditor | Chief Auditor | 2025 |
BU Authorized Recipient of Service | Authorized Recipient of Service | 2022 |
ER Chief Executive Officer | Chief Executive Officer | 2021 |
| Former (1) | ||
OA External Signatory | External Signatory | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2025 | |
| Former (4) | ||
| Deputy Board Member | 2021 – 2024 | |
| Deputy Board Member | 2024 – 2025 | |
| Deputy Board Member | 2021 – 2021 | |
| Board of Directors | 2021 – 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Dr. Wolff Sweden AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Olof Alexander Frånlund | External Signatory | 0 companies |
| Lajos Mathias Constantin Racz | Chief Auditor | 0 companies |
| Bettina Ulrike Schütz-Gärdén | Authorized Recipient of Service | 0 companies |
| Eduard Richard Dörrenberg | Chief Executive Officer | 0 companies |
| Nils Gregor Merkel | Deputy Board Member | 0 companies |
| Christian Mestwerdt | Deputy Board Member | 0 companies |
| Andreas Dr. Brinkhoff | Deputy Board Member | 0 companies |
| Eva Margareta Eljans | Deputy Board Member | 0 companies |
| Anita Helena Berggren | Board of Directors | 0 companies |